An exploration of how broadly neutralizing antibodies might induce HIV remission: the 'vaccinal' effect.
Journal article
Tipoe T. et al, (2022), Curr opin hiv aids, 17, 162 - 170
BreakAlign: a Perl program to align chimaeric (split) genomic NGS reads and allow visual confirmation of novel retroviral integrations.
Journal article
Marchi E. et al, (2022), Bmc bioinformatics, 23
The RIO trial: rationale, design, and the role of community involvement in a randomised placebo-controlled trial of antiretroviral therapy plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) in participants diagnosed with recent HIV infection-study protocol for a two-stage randomised phase II trial.
Journal article
Lee MJ. et al, (2022), Trials, 23
A simple, robust flow cytometry-based whole blood assay for investigating sex differential interferon alpha production by plasmacytoid dendritic cells.
Journal article
Sampson O. et al, (2022), J immunol methods, 504
Divergent trajectories of antiviral memory after SARS-CoV-2 infection.
Journal article
Tomic A. et al, (2022), Nat commun, 13
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.
Journal article
COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium. Electronic address: julian.knight@well.ox.ac.uk None. and COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium None., (2022), Cell, 185, 916 - 938.e58
Durability of ChAdOx1 nCov-19 vaccination in people living with HIV.
Journal article
Ogbe A. et al, (2022), Jci insight
Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological rebound.
Journal article
Zacharopoulou P. et al, (2022), Sci rep, 12
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses.
Journal article
Dejnirattisai W. et al, (2022), Cell
Human MAIT cells respond to and suppress HIV-1.
Journal article
Phetsouphanh C. et al, (2021), Elife, 10
Immunotherapeutic approaches to HIV cure and remission
Journal article
Lee MJ. et al, (2021), Current opinion in infectious diseases, Publish Ahead of Print
An HLA-I signature favouring KIR-educated Natural Killer cells mediates immune control of HIV in children and contrasts with the HLA-B-restricted CD8+ T-cell-mediated immune control in adults.
Journal article
Adriano Vieira V. et al, (2021), Plos pathog, 17
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine.
Journal article
Payne RP. et al, (2021), Cell
Robust HIV-specific CD4+ and CD8+ T-cell responses distinguish the rare phenotype of elite control in adolescents living with HIV from viraemic non-progressors.
Journal article
Vieira VA. et al, (2021), Aids
No evidence of neuronal damage as measured by neurofilament light chain in a HIV cure study utilising a kick-and-kill approach.
Journal article
Alagaratnam J. et al, (2021), J virus erad, 7
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial.
Journal article
Frater J. et al, (2021), Lancet hiv, 8, e474 - e485